Back
SPDR® Portfolio Long Term Treasury ETF Vs. Keros Therapeutics Industry Stock Comparison
Buy
53
SPTL
SPDR® Portfolio Long Term Treasury ETF
Last Price:
29.26
Seasonality Move:
1.08%
Sell
35
KROS
Keros Therapeutics
Last Price:
55.82
Seasonality Move:
37.33%
Buy
53
SPDR® Portfolio Long Term Treasury ETF (SPTL)
is a Buy
Is SPDR® Portfolio Long Term Treasury ETF a Buy, Sell or Hold?
- The current SPDR® Portfolio Long Term Treasury ETF [SPTL] share price is $29.34. The Score for SPTL is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- SPTL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
35
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $57.32. The Score for KROS is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- KROS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SPTL Stock Price Chart
What is SPDR® Portfolio Long Term Treasury ETF's stock price today?
-
The SPDR® Portfolio Long Term Treasury ETF share price today is $29.34
The current trend is moderately bearish and SPTL is experiencing buying pressure, which is a positive indicator for future bullish movement.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $57.32
The current trend is moderately bullish and KROS is experiencing slight buying pressure.
SPTL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.27 | Buy |
| Relative Strength Index (14 RSI): | 54.38 | Buy |
| Chaikin Money Flow: | 3307242 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.86 - 29.56) | Buy |
| Bollinger Bands (100): | (26.93 - 28.85) | Buy |
KROS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.54 | Buy |
| Relative Strength Index (14 RSI): | 69.78 | Buy |
| Chaikin Money Flow: | 11894 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.63 - 54.93) | Buy |
| Bollinger Bands (100): | (44.93 - 54.13) | Buy |
SPTL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.61 | Sell |
| 20-day SMA: | 29.27 | Buy |
| 50-day SMA: | 28.63 | Buy |
| 200-day SMA: | 27.83 | Buy |
| 8-day EMA: | 29.51 | Sell |
| 20-day EMA: | 29.3 | Buy |
| 50-day EMA: | 28.75 | Buy |
| 200-day EMA: | 28.03 | Buy |
KROS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 55.81 | Buy |
| 20-day SMA: | 51.2 | Buy |
| 50-day SMA: | 49.36 | Buy |
| 200-day SMA: | 52.15 | Buy |
| 8-day EMA: | 55.34 | Buy |
| 20-day EMA: | 52.61 | Buy |
| 50-day EMA: | 50.31 | Buy |
| 200-day EMA: | 49.54 | Buy |
SPDR® Portfolio Long Term Treasury ETF Earnings Growth & SPTL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.02 per share, an increase this year of $0.31 per share, and a decrease next year of $0.43 per share.
SPDR® Portfolio Long Term Treasury ETF Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Keros Therapeutics Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||